Partnership Uses Predictive Analytics to Address Medication Failure

DecisionRx Partners with MedeAnalytics to Power Value-Based Medication Optimization

RICHARDSON, Texas, July 17, 2025 /PRNewswire/ -- MedeAnalytics, a healthcare enterprise data enrichment platform and analytics software-as-a-service (SaaS) leader, today announced its partnership with DecisionRx, a leading technology-enabled healthcare services company specializing in medication therapy optimization (MTO). By incorporating the analytical capabilities of MedeAnalytics' Health Fabric™, DecisionRx will be able to expand its ability to quantify and communicate the clinical and economic impact of its work with payers and providers under value-based care contracts.

DecisionRx's MTO platform enables personalized prescribing decisions informed by data science, clinical guidelines, and pharmacist expertise. The platform is delivering measurable savings and improving outcomes for patients who face a high risk of medication failure, which often leads to increased costs for payers, providers, and patients. MTO can reduce the total annual cost of care by over $3,600 for Medicare patients and $1,200 for patients under the age of 65.

"We are excited to partner with MedeAnalytics to help quantify the clinical and economic impact in our value-based payer contracts," said Travis Morgan, President and Co-Founder of DecisionRx. "Our medication therapy optimization platform is currently unlocking 8–12% in total healthcare cost savings for thousands of patients with high polypharmacy risk. This partnership with MedeAnalytics expands our ability to seamlessly integrate and communicate with payers and providers to deliver better healthcare."

By leveraging MedeAnalytics' industry-leading outcomes analysis capabilities, DecisionRx is able to:

• Quantify the ROI of its clinical interventions using real-world data
• Track cost savings and utilization reductions across populations
• Measure and report performance on quality and value-based metrics
• Seamlessly communicate insights with payer and provider stakeholders
• Accelerate the adoption of its platform within value-based care frameworks

"DecisionRx is addressing a critical and costly gap in healthcare, medication failure," said Steve Grieco, CEO of MedeAnalytics. "We're proud to support their mission by equipping their team with robust, scalable outcomes analytics to track savings, optimize interventions, and advance their unique value-based care approach."

By combining artificial intelligence and machine learning with the industry's most advanced data orchestration capabilities, MedeAnalytics enables organizations like DecisionRx to optimize resource allocation, improve patient outcomes, and achieve population health management goals.

About MedeAnalytics
With over 30 years as a healthcare technology leader, MedeAnalytics provides the most powerful enterprise data enrichment platform and analytics solutions specifically built for healthcare. By harnessing the first fully curated, turnkey Health Fabric™, combined with Strategic Advisory services and artificial intelligence through our Data Science Factory™, its scalable, seamless, and transformational SaaS solutions enable measurable and transparent ROI via its Managed Action™ ecosystem. To learn more, visit MedeAnalytics' website, LinkedIn, and explore its featured insights.

About DecisionRx
DecisionRx is a technology-enabled healthcare services company improving patient outcomes and reducing healthcare costs by helping providers optimize prescribing decisions for their patients. DecisionRx clinical pharmacists work on patients' behalf to mitigate medication failure by making personalized medication recommendations to prescribers, informed by the latest clinical and data science, and delivered in a value-based care model. Medication failure accounts for at least 16% of total healthcare spending, and medication therapy optimization has been shown to reduce the total annual cost of care by over $3,600 for Medicare patients and $1,200 for patients under age 65. Learn more at DecisionRx's website.

Media Contact:

Jeff Rusack
Media Relations Manager
[email protected]

SOURCE MedeAnalytics